Literature DB >> 27639541

Interaction of an esophageal MEG protein from schistosomes with a human S100 protein involved in inflammatory response.

Débora Orcia1, Ana Eliza Zeraik1, José L S Lopes1, Joci N A Macedo1, Clarissa Romano Dos Santos1, Katia C Oliveira2, Leticia Anderson3, B A Wallace4, Sergio Verjovski-Almeida5, Ana P U Araujo1, Ricardo DeMarco6.   

Abstract

BACKGROUND: The Micro-Exon Gene-14 (MEG-14) displays a remarkable structure that allows the generation of antigenic variation in Schistosomes. Previous studies showed that the soluble portion of the MEG-14 protein displays features of an intrinsically disordered protein and is expressed exclusively in the parasite esophageal gland. These features indicated a potential for interaction with host proteins present in the plasma and cells from ingested blood.
METHODS: A yeast two-hybrid experiment using as bait the soluble domain of Schistosoma mansoni MEG-14 (sMEG-14) against a human leukocyte cDNA library was performed. Pull-down and surface plasmon resonance (SPR) experiments were used to validate the interaction between sMEG-14 and human S100A9. Synchrotron radiation circular dichroism (SRCD) were used to detect structural changes upon interaction between sMEG-14 and human S100A9. Feeding of live parasites with S100A9 attached to a fluorophore allowed the tracking of the fate of this protein in the parasite digestive system.
RESULTS: S100A9 interacted with sMEG-14 consistently in yeast two-hybrid assay, pull-down and SPR experiments. SRCD suggested that MEG-14 acquired a more regular structure as a result of the interaction with S100A9. Accumulation of recombinant S100A9 in the parasite's esophageal gland, when ingested by live worms suggests that such interaction may occur in vivo.
CONCLUSION: S100A9, a protein previously described to be involved in modulation of inflammatory response, was found to interact with sMEG-14. GENERAL SIGNIFICANCE: Our results allow proposing a mechanism involving MEG-14 for the parasite to block inflammatory signaling, which would occur upon release of S100A9 when ingested blood cells are lysed. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Intrinsically disordered proteins; Micro-exon gene; Protein-protein interaction; Synchrotron radiation circular dichroism spectroscopy

Mesh:

Substances:

Year:  2016        PMID: 27639541     DOI: 10.1016/j.bbagen.2016.09.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  6 in total

Review 1.  Going deep into protein secondary structure with synchrotron radiation circular dichroism spectroscopy.

Authors:  Patricia S Kumagai; Ana P U Araujo; Jose L S Lopes
Journal:  Biophys Rev       Date:  2017-08-19

2.  Microexon gene transcriptional profiles and evolution provide insights into blood processing by the Schistosoma japonicum esophagus.

Authors:  Xiao-Hong Li; Ricardo DeMarco; Leandro X Neves; Sally R James; Katherine Newling; Peter D Ashton; Jian-Ping Cao; R Alan Wilson; William Castro-Borges
Journal:  PLoS Negl Trop Dis       Date:  2018-02-12

3.  Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure.

Authors:  Paul McCusker; Claudia M Rohr; John D Chan
Journal:  PLoS Negl Trop Dis       Date:  2021-03-03

4.  Transcriptome of the parasitic flatworm Schistosoma mansoni during intra-mammalian development.

Authors:  Arporn Wangwiwatsin; Anna V Protasio; Shona Wilson; Christian Owusu; Nancy E Holroyd; Mandy J Sanders; Jacqueline Keane; Mike J Doenhoff; Gabriel Rinaldi; Matthew Berriman
Journal:  PLoS Negl Trop Dis       Date:  2020-05-06

5.  The esophageal gland mediates host immune evasion by the human parasite Schistosoma mansoni.

Authors:  Jayhun Lee; Tracy Chong; Phillip A Newmark
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-31       Impact factor: 11.205

Review 6.  Immune Evasion Strategies of Schistosomes.

Authors:  Jacob R Hambrook; Patrick C Hanington
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.